FMC 2Q Financials Released Published July 30, 2026 FMC had second-quarter revenue of $867 million, down 17 percent from the second quarter of 2025. During the quarter, FMC focused on reducing debt, improving the competitiveness of its core portfolio and managing the patent transition of Rynaxypyr. Share this:
